Psychiatric Comorbidity in Children with Autism Spectrum Disorders: A Comparison with Children with ADHD by unknown
ORIGINAL PAPER
Psychiatric Comorbidity in Children with Autism Spectrum
Disorders: A Comparison with Children with ADHD
Francisca J. A. van Steensel • Susan M. Bo¨gels •
Esther I. de Bruin
Published online: 1 May 2012
 The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract The present study was conducted with the aim
to identify comorbid psychiatric disorders in children with
autism spectrum disorders (ASD) (n = 40) and to compare
those comorbidity rates to those in children with attention
deficit hyperactivity disorder (ADHD) (n = 40). Partici-
pants were clinically referred children aged 7–18 years.
DSM-IV classifications were used for the primary diag-
nosis (ASD/ADHD), while comorbid psychiatric disorders
were assessed using a structured diagnostic interview, the
structured clinical interview for DSM-IV, childhood diag-
noses (KID-SCID). Twenty-three children with ASD
(57.5 %) had at least one comorbid disorder, whereas 16
children with ADHD (40.0 %) were classified as having at
least one comorbid disorder. No group differences were
found with respect to this comorbidity rate or for the rate of
comorbid externalizing disorders (ODD and/or CD).
However, children with ASD had more comorbid inter-
nalizing disorders compared to children with ADHD. More
specifically, children with ASD had higher rates of anxiety
disorders, but not mood disorders. No associations between
comorbidity and age or between comorbidity and the
intelligence quotient was found. It is important for clini-
cians to always be aware of, and screen for, comorbidity,
and to consider treatment for these comorbid disorders. In
addition, research should focus on establishing valid and
reliable screening tools as well as effective treatment
options for these comorbid disorders.
Keywords ASD  ADHD  Children 
Psychiatric comorbidity
Introduction
Children with autism spectrum disorders are characterized
not only by their core deficits, impairments in social
interaction and communication and repetitive stereotyped
behaviors (APA, DSM-IV-TR 2000), but they also suffer
from many comorbid features such as anxiety, depression,
ADHD and behavioral problems (e.g. Leyfer et al. 2006).
An important distinction, however, is the presence of
comorbid symptoms versus comorbid disorders. For a full
clinical picture of a child it is valuable to be informed with
respect to his/her comorbid symptoms but often additional
treatment options are more likely to be offered when a
DSM-IV disorder is classified. While several studies have
examined comorbid psychiatric symptoms in children with
ASD (e.g. Gadow et al. 2005; Kim et al. 2000), studies that
have examined the presence of comorbid psychiatric dis-
orders are less common, particularly using standardized
diagnostic interviews. We have identified ten of those
studies (Table 1). In these studies, rates for at least one
comorbid disorder vary between 63.3 % (Amr et al. 2012)
and 96.4 % (Mukaddes et al. 2010). In addition, studies
differ with respect to the most common disorder that is
found, and rates for each specific disorder vary consider-
ably (Table 1).
Factors that might be relevant to consider for their
influence on comorbidity rates are gender, age and intel-
ligence quotient (IQ). No significant gender differences in
the rates of comorbid disorders were found in the study of
Simonoff et al. (2008) and in the study of Gjevik et al.
(2011). With respect to age, the study of Matilla et al.
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(2010) found that psychiatric comorbidity was more
common in primary school-aged children with ASD
compared to secondary school-aged children. Mixed
results have been found for comorbidity and its relation
with IQ: in the study of Simonoff et al. (2008) and the
study of Gjevik et al. (2011), IQ was not associated with
psychiatric comorbidity, while in the study of Witwer and
Lecavalier (2010) children with an IQ below 70 had fewer
psychiatric symptoms compared to children with an IQ
above 70. Alternatively, children with ASD and an IQ
below 70 may have poorer language skills to communicate
(psychiatric) symptoms or internal feelings (to their care-
givers), which could contribute to such findings.
Child psychiatric disorders can be roughly divided into
two main groups: internalizing and externalizing (or dis-
ruptive behavior) disorders. Internalizing disorders are
characterized by behaviors and emotions that are directed
inwards and include mood disorders (e.g. major depressive
disorder, dysthymic disorder) and anxiety disorders (e.g.
separation anxiety disorder, social anxiety disorder,
obsessive–compulsive disorder, specific phobia). Exter-
nalizing disorders are characterized by behaviors and
emotions directed outwards and include ADHD, opposi-
tional defiant disorder (ODD) and conduct disorder (CD).
Since ADHD seems the most commonly reported comor-
bid disorder in children with ASD (Table 1), it is important
to (1) explore differences and similarities between children
with ASD and children with ADHD, and (2) to compare
the prevalence of comorbid psychiatric disorders across
those clinical groups. However, studies addressing these
issues are rare. One study compared children with ADHD
alone, children with ASD ? ADHD and children with
chronic multiple tic disorder ? ADHD and found simi-
larities as well as differences in comorbidity of symptoms
among groups (Gadow et al. 2009). Similarities for all
groups were found for ODD and CD symptoms, whereas
differences between groups were found for anxiety symp-
toms. Children with ASD ? ADHD were generally rated
to have more severe anxiety symptoms compared to the
other groups. In addition, Green and colleagues compared
20 adolescents with Aspergers’ Syndrome to 20 adoles-
cents with CD and also found adolescents with Aspergers’
Syndrome to have more anxiety-related symptoms (Green
et al. 2000).
To conclude, several studies have examined psychiatric
comorbid disorders by using structured diagnostic inter-
views in children with ASD, however, comparative studies
between ASD and other clinical groups (such as ADHD)
on comorbid psychiatric disorders are rare. Examining
comorbidity in clinical samples is important because they
may influence the symptoms of the primary diagnosis (e.g.
anxiety symptoms may exacerbate ASD-symptoms; Wood
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outcomes (Matson and Nebel-Schwalm 2007). Further-
more, knowing which comorbid disorders are (more) likely
to exist in a particular clinical sample, may lead to (early)
screening activities and (the development of) prevention
programs. Therefore, the current study aims to examine
comorbid disorders in children with ASD and to compare
them to a group of children with ADHD. In addition, the
relation between comorbidity and age, and between
comorbidity and IQ, was explored (gender was not exam-
ined because of power issues).
Method
Participants
All children were referred to a general outpatient mental
health center in Maastricht, the Netherlands. In total 80
children, aged 7–18, and their parent(s) participated: 40
children had a primary DSM-IV-TR classification of ASD,
and 40 children had a primary DSM-IV-TR classification
of ADHD (based on a multi-disciplinary consensus diag-
nosis, see procedure). No standardized measures were used
to confirm the primary diagnosis. However, we are confi-
dent about the reliability of the ASD classification since in
another sample of children with ASD, partly from the same
outpatient mental health care center, the agreement
between a clinical DSM-IV-TR classification of ASD and
an ASD classification based on the Autism Diagnostic
Interview-Revised (ADI-R; Lord et al. 1994) was excellent
(97.8 %; van Steensel, Bo¨gels and de Bruin, submitted). In
addition, the KID-SCID (Hien et al. 1994; Dutch transla-
tion by Dreessen et al. 1998) was used to assess psychiatric
comorbid disorders of which one is ADHD. For 36 out of
the 40 children (90 %) classified as having ADHD, an
ADHD- diagnosis was confirmed by the KID-SCID. That
means that four children did not meet KID-SCID criteria
for ADHD. It was decided not to exclude these children
because—after disclosure of the KID-SCID results—these
children still received a DSM-IV based diagnosis of ADHD
as established by the multi-disciplinary team based on
other diagnostic criteria (e.g. the cognitive profile on the
Wechsler Intelligence Scale for Children-Revised, WISC-
R (Wechsler 1974; van Haasen et al. 1986), the ratings on
the Child Behavior Check List, CBCL (Achenbach 1991),
and/or the impairment of attention problems for those
children in daily functioning).
Of the children with ASD, 28 (70.0 %) were diagnosed
with PDD-NOS and 12 children were diagnosed with As-
pergers’ Syndrome (30.0 %). Of the ADHD sample, 23
children were classified as having ADHD-combined type
(57.5 %), nine as having ADHD-inattentive type (22.5 %)
and five as having ADHD-hyperactivity type (12.5 %). For
three children (7.5 %), DSM-IV-TR classification of
ADHD was postponed (i.e. a formal diagnosis of ADHD
was not received because families dropped out). However,
we decided not to exclude those three children from the
study because they all met DSM-IV criteria of ADHD
based on the KID-SCID. None of the children in the
ADHD sample were suspected of having ASD.
The ASD sample consisted of 36 boys and four girls with a
mean age of 11.10 years (range = 8–18 years; SD = 2.82).
The ADHD sample consisted of 37 boys and three girls and
had a mean age of 11.13 years (range = 7–17 years; SD =
2.85). No group differences were found for gender, X2
(1) = 0.157; p = .692, or age, F (1, 78) = 0.002; p = .969.
For a summary of the education level and cognitive func-
tioning of both groups, see Table 2. No differences between
groups were found for primary education level, X2(1) = 0.005;
p = 1.00, secondary education level, Mann-Whitney U =
43.50; p = .260, or level of cognitive functioning, Mann–
Whitney U = 487.50; p = .371.
Instrument
The KID-SCID (Hien et al. 1994; Dutch translation by
Dreessen et al. 1998) was used to assess (comorbid) psy-
chiatric DSM-IV disorders. The KID-SCID is based on the
widely used adult SCID with the questions adapted for
applicability to children (and with additional childhood
disorders). The adult SCID has demonstrated acceptable
reliability and validity levels (e.g. Basco et al. 2000;
Lobbestael et al. 2011; Spitzer et al. 1992; Williams et al.
1992). In addition, several studies support the validity and
reliability of the KID-SCID (Matzner 1994; Matzner et al.
1997; Smith et al. 2005; Trimbremont et al. 2004). Kappa
values for the test–retest reliability of the KID-SCID were
found to range from .63 to .84 for the disruptive behavior
disorders (kappa was .84, .63, and .84 for ADHD, ODD,
and CD respectively) and from .44 to 1.0 for the anxiety
disorders (kappa was 1.0, .66, and .44 for social anxiety
disorder, separation anxiety disorder, and post-traumatic
stress disorder, respectively) (Matzner et al. 1997). In
addition, kappa values for the inter-rater reliability were
1.0 for disruptive behavior disorders, .63 for anxiety dis-
orders, and .76 for the diagnosis of a current major
depressive disorder (Trimbremont et al. 2004).
In administering the KID-SCID, a respondent is asked
whether a particular DSM-IV symptom is present. The
symptom is rated as: (1) absent, (2) possibly present, or (3)
present. Both child and parent(s) provide answers and the
interviewer combines the information of all respondents to
rate a ‘best’ score. Next, the number of symptoms rated as
‘present’ is counted. If the required number of symptoms is
met (i.e. the DSM-IV symptom-criterion is met), the inter-
viewer asks about other DSM-criteria (such as ‘at what age
370 J Child Fam Stud (2013) 22:368–376
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symptoms emerged’ or ‘whether symptoms cause interfer-
ence with daily activities’). Finally, a KID-SCID diagnosis
is obtained when all DSM-IV criteria are met. In the present
study, information was obtained from parent(s) and child
and the following sections of the KID-SCID were admin-
istered: disruptive behavior disorders (ADHD, ODD and
CD), mood disorders (major depressive disorder and dys-
thymic disorder) and anxiety disorders (separation anxiety
disorder, social anxiety disorder, specific phobia, general-
ized anxiety disorder, obsessive–compulsive disorder, panic
disorder, agoraphobia, post-traumatic stress disorder, and
anxiety disorder not otherwise specified).
Procedure
DSM-IV classification of ASD or ADHD was established
by a multi-disciplinary team of psychologists, therapists,
social workers and child psychiatrists, and was based on
clinical evaluations. Clinical evaluations included for
example interviews with parent(s) and child, observations
of child-parent interaction, school observations, diagnostic
assessments (e.g. WISC-R, Wechsler 1974; Van Haasen
et al. 1986; CBCL, Achenbach 1991) and/or psychiatric
consults. Approval was given by the medical-ethical
committee, and participants signed informed consent. The
KID-SCID was part of the intake procedure in the outpa-
tient mental health center and was administered by psy-
chologists who had multiple years of experience with the
assessment and treatment of children with psychiatric dis-
orders. In addition, the interviewers were trained by the
translators of the KID-SCID who themselves were exten-
sively trained in the use of the adult SCID.
Analyses
Frequency counts of the psychiatric comorbid disorders for
both groups were calculated. First, the overall comorbidity
rate as well as the rates for internalizing and externalizing
comorbid disorders in children with ASD and ADHD were
compared using Chi-square analyses. If this test reached
significance, then additional Chi-square analyses were
conducted to explore group differences within the inter-
nalizing (mood/anxiety disorders) or externalizing (ODD/
CD) disorders. In addition, the relation between comor-
bidity and age and between comorbidity and IQ was
explored with Spearman’s rho. Considering the explorative
nature of the research questions, alpha levels were set at .05
for all analyses.
Results
Children with ASD were classified as having a comorbid
disorder if they met KID-SCID criteria for at least one
comorbid disorder. In line with the CBCL manual
(Achenbach 1991) we defined participants as having a
comorbid externalizing disorder if they met KID-SCID
criteria for ODD and/or CD. Participants were classified to
have an internalizing disorder if they met KID-SCID cri-
teria for at least one mood disorder (major depressive
disorder or dysthymic disorder) and/or one anxiety disorder
(separation anxiety disorder, social anxiety disorder,
specific phobia, generalized anxiety disorder, obsessive–
compulsive disorder, panic disorder, agoraphobia, post-
traumatic stress disorder, or anxiety disorder not otherwise
specified).
In Table 3 the frequencies of the comorbid disorders for
both samples are displayed. In the ASD sample, twenty-
three children (57.5 %) were classified as having a
comorbid disorder; internalizing disorders (35.0 %) were
somewhat more common than externalizing disorders
Table 2 Education level and cognitive functioning of the ASD and
ADHD sample
ASD (n = 40) ADHD (n = 40)
n % n %
Schoola
Primary (elementary)
Special 2 5.0 2 5.0
Regular 28 70.0 26 65.0
Secondary
Special 1 2.5 4 10.0
Low level 1 2.5 1 2.5
Moderate level 3 7.5 3 7.5
High level 3 7.5 3 7.5
Vocational
Low level 1 2.5 1 2.5
Moderate level 0 0.0 0 0.0
High level 1 2.5 0 0.0
Cognitive functioning (IQ)
50–69 2 5.0 0 0.0
70–79 4 10.0 3 7.5
80–89 0 0.0 5 12.5
90–110 16 40.0 11 27.5
111–120 9 22.5 11 27.5
121–130 3 7.5 0 0.0
[130 3 7.5 0 0.0
IQ data not available 3 7.5 10 25.0
a Schools in the Netherlands are divided in primary, secondary and
vocational schools. Secondary and vocational schools are split into
three education levels: low, moderate and high. Special education is
viewed as a separate category; however, all levels (low-moderate-
high) may be present. After graduation, transfers are possible (1) from
a lower to a higher level within secondary or vocational schools and
(2) from a secondary to a vocational school with the same level
J Child Fam Stud (2013) 22:368–376 371
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(22.5 %). Sixteen children of the ADHD-sample (40.0 %)
met criteria for a comorbid disorder (note that for children
with ADHD a KID-SCID diagnosis of ADHD was exclu-
ded from this comorbidity rate); externalizing disorders
(27.5 %) being somewhat more common than internalizing
disorders (12.5 %).
The two groups did not differ with respect to their
overall rate of comorbid disorders, X2(1) = 2.45;
p = .117. Group differences were found to be significant
for internalizing disorders, X2(1) = 5.59; p = .018, but not
for externalizing disorders, X2(1) = 0.27; p = .606. Chil-
dren with ASD had significantly more internalizing disor-
ders compared to children with ADHD. Of the internalizing
disorders, children with ASD were found to have signifi-
cantly more anxiety disorders, X2(1) = 4.02; p = .045, but
not mood disorders, X2(1) = 1.41; p = .432, compared to
children with ADHD.
Correlations between comorbidity and age, and between
comorbidity and IQ, are displayed in Table 4. Correlations
were only small and none were found to be significant (all
p’s [ .10) indicating no relation between the presence of
comorbidity and age, or between the presence of comorbid
disorders and IQ.
Discussion
The present study examined psychiatric comorbidity in
children with ASD and compared this to a group of chil-
dren with ADHD. This was the first study to compare these
two groups with respect to the frequencies of comorbid
disorders (instead of symptoms) with a structured diag-
nostic interview. Children with ASD did not differ from
children with ADHD with respect to their overall comor-
bidity rate. However, anxiety disorders were more often
present in children with ASD compared to children with
ADHD.
The finding that children with ASD and ADHD do not
differ with respect to their overall comorbidity rate is not
very surprising, since a review of comorbidity in children
with ADHD (Gillberg et al. 2004) reported similar
comorbidity rates (60–100 %) to those found by studies
focusing on children with ASD (63.3–96.4 %, see
Table 1). However, the finding is interesting for the fol-
lowing two reasons. First, comorbidity rates of children
with ASD have not been compared directly to children with
ADHD before. In addition, comparing the comorbidity
rates between studies that have included children with ASD
versus children with ADHD is difficult because of the wide
variability in study designs, measurements to assess psy-
chiatric comorbidity and study samples (i.e. community-
based versus clinic-based samples). Secondly, the present
findings suggest that children with ASD and children with
ADHD are equally likely to develop comorbid psychiatric
disorders, although specific comorbid disorders may be
more present in one group than the other.
In the present study it was found that children with ASD
exhibit more anxiety disorders compared to children with
ADHD. This may partly be due to overlap between the core
symptoms of ASD and symptoms of anxiety, particular in
the case of obsessive–compulsive disorder and social
anxiety disorder [see for example Wood and Gadow (2010)
and van Steensel et al. (2011) for some discussion about
this issue]. Nevertheless, our finding that children with
ASD would have more anxiety disorders is in agreement
with the study of Gadow et al. (2009) which found children
with ASD to have more anxiety symptoms compared to
children with ADHD. In addition, anxiety symptoms are
usually not the core deficits in children with ASD, how-
ever, they respond favorably to treatment and extensive
Table 3 Frequency of comorbid psychiatric disorders in children





n % n %
Comorbid disordera 23 57.5 16 40.0
Internalizing disordersb 14 35.0 5 12.5
Anxiety disorders 11 27.5 4 10.0
Separation anxiety disorder 1 2.5 2 5.0
Social anxiety disorder 4 10.0 1 2.5
Specific phobia 5 12.5 1 2.5
Generalized anxiety disorder 2 5.0 0 0.0
Obsessive–compulsive disorder 3 7.5 0 0.0
Panic disorder 1 2.5 0 0.0
Agoraphobia 0 0.0 0 0.0
Post-traumatic stress disorder 0 0.0 0 0.0
Anxiety disorder not otherwise specified 0 0.0 0 0.0
Mood disorders 5 12.5 2 5.0
Major depressive disorder 1 2.5 2 5.0
Dysthymic disorder 4 10.0 0 0.0
Externalizing disordersc 9 22.5 11 27.5
Oppositional defiant disorder 9 22.5 8 20.0
Conduct disorder 1 2.5 5 12.5
Attention deficit hyperactivity disorder 9 22.5 36 90.0d
a Participants met KID-SCID criteria for at least one comorbid dis-
order (for the ADHD sample a KID-SCID diagnosis of ADHD was
excluded)
b Participants met KID-SCID criteria for at least one anxiety disorder
and/or mood disorder
c Participants met KID-SCID criteria for ODD and/or CD
d Group assignment was based on clinical diagnosis and therefore it
was possible that not all participants with ADHD were having an
ADHD diagnosis according to the KID-SCID
372 J Child Fam Stud (2013) 22:368–376
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protocols for pharmacotherapy, and behavioral therapy for
these additional anxiety symptoms in ASD is available
(e.g. Posey and McDougle 2000; Santosh and Baird 2001).
It is thus important to be aware of these comorbid symp-
toms, because not only are they treatable (whereas the core
ASD symptoms are not), not treating them may lead to
extra impairments in daily life skills such as completing
school work or engaging in social situations. In addition, it
is commonly found that children with ASD have higher
levels of anxiety compared to typically developing children
(e.g. Kim et al. 2000), however, for children with ADHD,
as compared to typically developing children, these find-
ings are more mixed (e.g. Biederman et al. 1991; Gau et al.
2010; van den Heuvel et al. 2007).
Also in line with the study of Gadow et al. (2009), we
found that children with ASD and ADHD do not differ with
respect to comorbid externalizing disorders (ODD/CD). In
addition, in general, comorbidity between ADHD and
ODD/CD is higher than between ADHD and internalizing
disorders (e.g. Gillberg et al. 2004). Of note, in post hoc
analyses we also found that children with ASD and a
comorbid diagnosis of ADHD (n = 9) were significantly
more likely to have ODD/CD (but not internalizing disor-
ders) compared to those children with ASD without a
comorbid ADHD-diagnosis (n = 31).
In contrast, we did not find higher levels of mood disorders
in children with ASD. Note also that in Gadow et al. (2009)
symptoms instead of disorders were assessed, which may
explain the disagreement. Important to add here is that our
study sample consisted of school-aged children only. From
studies of Ghaziuddin et al. (2002) it is known that the rate of
depression in ASD may rise with age. From the adolescent
phase, and even more so for (young) adults, depression (i.e. a
mood disorder) is the most common comorbid disorder in
people with ASD (Ghaziuddin et al. 2002). It is therefore
likely that our findings regarding comorbidity are not repre-
sentative for the different stages of a life with ASD. Possibly,
differences between ADHD and ASD become more promi-
nent later in life (Roeyers et al. 1998).
For children with ASD specifically, it was found that
57.5 % suffered from comorbid disorders. This percentage
is somewhat lower compared to the rates found in
comparable studies (63.3–96.4 %, see Table 1). A first
explanation for the relatively low rate we found is that we
included only internalizing and externalizing disorders,
excluding disorders such as enuresis, encopresis, chronic
tic disorder, Tourette’s syndrome, and schizophrenia,
which were included in several previous studies. A second
explanation for the relatively low percentage of comor-
bidity might be related to the center to which the children
of our sample were referred to. This was a general outpa-
tient mental health clinic, not particularly specialized in
ASD. As such, children with a large heterogeneity in
psychiatric problems were referred, and possibly the more
severe or complex cases (with higher comorbidity) were
referred to more specialized centers. A third explanation
for the relatively low comorbidity rate is that in most other
studies different standardized interviews were used (e.g.
the Diagnostic Interview Schedule for Children [DISC-IV;
Ferdinand and Van der Ende 1998; Shaffer et al. 1996] in
the study of De Bruin et al. 2007). The KID-SCID, similar
to the DSM-IV, includes a criterion that the symptoms of
ADHD, separation anxiety disorder, social anxiety disorder
and generalized anxiety disorder may not be explained by
the presence of an ASD. This criterion may have lowered
the comorbidity rates of those disorders in the current
study. Nonetheless, the percentage of comorbidity in chil-
dren with ASD found in the current study (57.5 %) is still
much higher compared to the rates (9.5–14.5 %) com-
monly found in typically developing children (e.g. Meltzer
2007; Ravens-Sieberer et al. 2008; Scholte et al. 2008).
Finally, limitations of the study need to be addressed.
First, a larger sample size would have more power to detect
possible influences of age and IQ. For example, the sample
size of the current study was too small to examine possible
influences of age or IQ for each specific disorder individ-
ually (e.g. social anxiety disorder, dysthymic disorder,
etc.). In addition, while we did not find a significant rela-
tion between age (or IQ) and comorbidity in the present
study, other studies did find differences across specific
disorders for the influence of age in children with ASD
(e.g. Matilla et al. 2010 found that behavioral disorders in
children with ASD decreased with age, and Gjevik
et al. 2011 found children with ASD and comorbid
Table 4 Correlations between comorbidity and age, and between comorbidity and IQ
Total (n = 80) ASD (n = 40) ADHD (n = 40)
COMORBID INT EXT COMORBID INT EXT COMORBID INT EXT
Age .07 .03 .10 .17 .23 .06 .00 -.21 .15
IQa -.01 .15 -.11 .07 .19 -.05 -.19 -.05 -.18
COMORBID having at least one comorbid disorder (for the ADHD sample a diagnosis of ADHD was excluded), EXT having at least one
externalizing disorder (ODD/CD), INT having at least one internalizing disorder (anxiety/mood disorder)
a IQ-data was not available for three children with ASD and for ten children with ADHD
J Child Fam Stud (2013) 22:368–376 373
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obsessive–compulsive disorder to be significantly older
compared to those without obsessive–compulsive disor-
der). Further, the influence of other factors such as gender
or ASD/ADHD subtype would be interesting to examine,
however, this was not possible in the present study because
of power issues. A second limitation is the overlap between
ASD and ADHD. That is, a number of children with ASD
(n = 9, 22.5 %) also had ADHD (according to KID-SCID
criteria) and were found to differ from children with ASD
without ADHD with respect to the rates of comorbid
externalizing disorders. None of the children with ADHD
were suspected to have ASD, however, although we have
not assessed ASD symptoms in children with ADHD in the
present study, it is likely that some of these children had
(sub-) clinical levels of ASD symptoms. That is, other
studies (e.g. Kochhar et al. 2011) have found higher levels
of ASD traits in children with ADHD compared to typi-
cally developing children, and a substantial proportion of
those children with ADHD reached screening thresholds
predictive for an ASD diagnosis. It is possible that such
overlap blurs the comparison between the two groups.
Third, with respect to the diagnostic instrument (KID-
SCID) it needs to be noted that psychometric studies are
still ongoing. Results of studies examining the KID-SCID
so far yielded fair to excellent test–retest reliability and
inter-rater reliability (Matzner 1994; Matzner et al. 1997;
Smith et al. 2005; Trimbremont et al. 2004), however,
studies examining the validity of the KID-SCID are rare. A
last limitation of the study is that we did not confirm ASD
classification by standardized assessments such as the ADI-
R (Lord et al. 1994) or the Autism Diagnostic Observation
Schedule Generic (ADOS-G; Lord et al. 1999).
To the authors’ knowledge, this was the first study to
examine the rate of psychiatric disorders in children with
ASD and compared this to a group of children with ADHD,
by using a structured and standardized diagnostic inter-
view. It was found that children with ASD were equally
likely to suffer from mood disorders and externalizing
disorders (ODD/CD) as children with ADHD; however,
they showed significantly more anxiety disorders compared
to children with ADHD. Considering the large comorbidity
found in children with ASD (and ADHD), clinicians should
be alert of, and ideally, should always screen for comorbid
disorders. Not only may these disorders interfere with daily
functioning over and above the core symptoms of ASD,
they may also exacerbate ASD-symptoms (Wood and
Gadow 2010). However, reliable and valid screening
instruments for assessing comorbidity as well as effective
treatment programs for treating comorbidity in the ASD
population are yet to be established. Note that there is a
small but growing body of evidence to suggest that cog-
nitive-behavioral therapies are effective for the treatment
of anxiety disorders in youth with high-functioning ASD
(e.g. Chalfant et al. 2007; Sofronoff et al. 2005; Wood et al.
2009), however, additional research is needed to examine
the long-term follow up and factors that might influence
treatment outcome. Furthermore, research concerning pre-
vention programs as well as treatment options for the more
challenging cases (e.g. children with intellectual disabili-
ties or multiple comorbid disorders) is specifically needed.
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